A novel HPLC-UV method for determining alendronate in rat plasma through precolumn derivatization with phenyl isothiocyanate: Application to pharmacokinetics

References

• Lin, J. H.; Chen, I. W.; Deluna, F. A.; Hichens, M. Renal Handling of Alendronate in Rats. An Uncharacterized Renal Transport System. Drug Metab. Dispos. 1992, 20, 608–613.
   PubMed Web of Science ®Google Scholar
• Fleisch, H. New Bisphosphonates in Osteoporosis. Osteoporosis Int. 1993, 3(Suppl 2), S15–S22.
   Google Scholar
• Stepensky, D.; Golomb, G.; Hoffman, A. Pharmacokinetic and Pharmacodynamic Evaluation of Intermittent Versus Continuous Alendronate Administration in Rats. J. Pharm. Sci. 2002, 91, 508–516.
   PubMed Web of Science ®Google Scholar
• Azuma, Y.; Sato, H.; Oue, Y.; Okabe, K.; Ohta, T.; Tsuchimoto, M.; Kiyoki, M. Alendronate Distributed on Bone Surfaces Inhibits Osteoclastic Bone Resorption In Vitro and in Experimental Hypercalcemia Models. Bone 1995, 16, 235–245.
   PubMed Web of Science ®Google Scholar
• Lin, J. H.; Russell, G.; Gertz, B. Pharmacokinetics of Alendronate: An Overview. Int. J. Clin. Pract. 1999, 101, 18–26.
   Google Scholar
• Lin, J. H.; Duggan, D. E.; Chen, I. W.; Ellsworth, R. L. Physiological Disposition of Alendronate, a Potent Anti-Osteolytic Bisphosphonate, in Laboratory Animals. Drug Metab. Dispos. 1991, 19, 926–932.
   PubMed Web of Science ®Google Scholar
• Chae, J. W.; Seo, J. W.; Mahat, B.; Yun, H. Y.; Baek, I. H.; Lee, B. Y.; Kim, D. H.; Kwon, K. I. A Simple Pharmacokinetic Model of Alendronate Developed Using Plasma Concentration and Urine Excretion Data from Healthy Men. Drug Dev. Ind. Pharm. 2014, 40, 1325–1329.
   PubMed Web of Science ®Google Scholar
• Porras, A. G.; Holland, S. D.; Gertz, B. J. Pharmacokinetics of Alendronate. Clin. Pharm. 1999, 36, 315–328.
   Google Scholar
• Raju, S. P. K.; Narayanam, M.; Kumar, B. K.; Tejaswee, S.; Singh, S. Validated Stability-Indicating Method for Alendronate Sodium Employing Zwitterionic Hydrophilic Interaction Chromatography Coupled with Charged Aerosol Detection. Chromatographia 2015, 78, 1245–1250.
   Web of Science ®Google Scholar
• Kline, W. F.; Matuszewski, B. K. Improved Determination of the Bisphosphonate Alendronate in Human Plasma and Urine by Automated Precolumn Derivatization and High-Performance Liquid-Chromatography with Fluorescence and Electrochemical Detection. J. Chromatogr. Biomed. Appl. 1992, 583, 183–193.
   Web of Science ®Google Scholar
• Yun, M. H.; Woo, J. S.; Kwon, K. I. Bioequivalence and Pharmacokinetics of 70 mg Alendronate Sodium Tablets by Measuring Alendronate in Plasma. Arch. Pharm. Res. 2006, 29, 328–332.
   PubMed Web of Science ®Google Scholar
• Liu, G.; Lu, T.; Sheng, P.; Qi, Y.; Mei, Q. RP-HPLC Determination of Alendronate Sodium in Rats Plasma. Chin. J. Pharm. Anal. 2008, 28, 2118–2121.
   Google Scholar
• Kwong, E.; Chiu, A. M.; McClintock, S. A.; Cotton, M. L. HPLC Analysis of an Amino Bisphosphonate in Pharmaceutical Formulations Using Postcolumn Derivatization and Fluorescence Detection. J. Chromatogr. Sci. 1990, 28, 563–566.
   PubMed Web of Science ®Google Scholar
• Ban, E.; Park, J. Y.; Kim, H. T.; Kim, C. K. Determination of Alendronate in Low Volumes of Plasma by Column-Switching High-Performance liquid Chromatography Method and its Application to Pharmacokinetic Studies in Human Plasma. Arch. Pharmacal Res. 2011, 34, 2079–2086.
   PubMed Web of Science ®Google Scholar
• Kang, H. S.; Hwang, S. J.; Park, J. S.; Kim, C. K. HPLC Method Validation and Pharmacokinetic Study of Alendronate Sodium in Human Urine with Fluorescence Detection. J. Liq. Chromatogr. Relat. Technol. 2006, 29, 1589–1600.
   Web of Science ®Google Scholar
• Yun, M. H.; Kwon, K. High-Performance Liquid Chromatography Method for Determining Alendronate Sodium in Human Plasma by Detecting Fluorescence: APPLICATION to a Pharmacokinetic Study in Humans. J. Pharm. Biomed. Anal. 2006, 40, 168–172.
   PubMed Web of Science ®Google Scholar
• Meng, J.; Meng, Q.; Zheng, L. A Simple and Rapid High-Performance Liquid Chromatography Method for Determination of Alendronate Sodium in Beagle Dog Plasma with Application to Preclinical Pharmacokinetic Study. Biomed. Chromatogr. 2010, 24, 169–173.
   PubMed Web of Science ®Google Scholar
• Al Deeb, S. K.; Hamdan, I. I.; Al Najjar, S. M. Spectroscopic and HPLC Methods for the Determination of Alendronate in Tablets and Urine. Talanta 2004, 64, 695–702.
   PubMed Web of Science ®Google Scholar
• Walash, M. I.; Metwally, M. E.; Eid, M.; El-Shaheny, R. N. Validated Spectrophotometric Methods for Determination of Alendronate Sodium in Tablets Through Nucleophilic Aromatic Substitution Reactions. Chem. Cent. J. 2012, 6, 25.
   PubMed Web of Science ®Google Scholar
• Callejon, R. M.; Troncoso, A. M.; Morales, M. L. Determination of Amino Acids in Grape-Derived Products: A Review. Talanta 2010, 81, 1143–1152.
   PubMed Web of Science ®Google Scholar
• Mayer, P. R.; Brazzell, R. K. Application of Statistical Moment Theory to Pharmacokinetics. J. Clin. Pharmacol. 1988, 28, 481–483.
   PubMedGoogle Scholar
• Katsumi, H.; Liu, S.; Tanaka, Y.; Hitomi, K.; Hayashi, R.; Hirai, Y.; Kusamori, K.; Quan, Y. S.; Kamiyama, F.; Sakane, T.; Yamamoto, A. Development of a Novel Self-Dissolving Microneedle Array of Alendronate, a Nitrogen-Containing Bisphosphonate: Evaluation of Transdermal Absorption, Safety, and Pharmacological Effects After Application in Rats. J. Pharm. Sci. 2012, 101, 3230–3238.
   PubMed Web of Science ®Google Scholar